Exploratory assessment of catestatin and thrombospondin-1 as potential biomarkers of disease severity and treatment response in pulmonary arterial hypertension.
PURPOSE Pulmonary arterial hypertension (PAH) is a rare disease associated with high morbidity and mortality. This exploratory study evaluated the effects of treatment escalation on cardiac function and circulating biomarkers, including N-terminal pro-B-type natriuretic peptide (NT-proBNP), catestatin, and thrombospond...